Not enough contributors have reported Mecasermin (rhIGF-1) side effects yet to show cohort frequencies safely (we suppress cohorts under n=25 so no one can be identified). Check back as the community grows.
We only publish cohort frequencies once enough people have reported them, so no one can be identified. So far Mecasermin (rhIGF-1) has 0 contributors and 0 data points, below our display threshold.
Self-reported by users, unverified. Not medical advice and not an endorsement of any substance. 18+ only.